Medical Laboratory Observer

Founded in 1969, Medical Laboratory Observer (MLO) serves as a valuable resource for clinical laboratory professionals. It offers access to peer-reviewed articles, continuing education (CE) opportunities, management advice for labs, and the latest advancements in molecular diagnostics. Additionally, MLO covers topics like infection control, oncology, pathology practices, regulatory changes, industry developments, and reviews of new products.

National, Trade/B2B

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#1255735

United States

#644047

Health/Health

#10327

Traffic sources

Monthly visitors

Articles

CMS-2567 has been published

1 week ago | mlo-online.com | Erin Brady

The Directors, Quality, Safety & Oversight Group (QSOG) and Survey & Operations Group (SOG) have published CMS-2567: Statement of Deficiencies and Plan of Correction. The memo aims to help patients receive straightforward healthcare so they can make the best decisions about their care.
Broadening accessibility of aggressive cancer treatment

1 week ago | mlo-online.com | Erin Brady

Mayo Clinic has opened the Duan Family Building to make aggressive cancer treatment more accessible, according to an announcement. • None The first carbon ion therapy program in the Americas, projected to be available by 2028
IU professor’s research aids FDA clearance of Alzheimer's blood test

1 week ago | mlo-online.com | Erin Brady

Indiana University School of Medicine professor Jeff Dage, PhD’s research aided the Food and Drug Administration (FDA) clearance of Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, according to a release. Dr. Dage “helped lead the discovery and development of one of the biomarkers the test identifies.” He hopes it will help broaden the accessibility of Alzheimer's testing.
Study says it takes patients longer to recover mentally from COVID symptoms

1 week ago | mlo-online.com | Erin Brady

A recent UCLA-led study found that it takes people experiencing symptoms of COVID longer to recover mentally than physically. According to a release, “people with COVID-like symptoms returned to optimal physical well-being an average of three months after infection but took up to nine months to return to top mental well-being.” 20% of participants still reported a low quality of life due to their health one year after being sick.
UC San Diego scientists develop new Alzheimer’s gene therapy

1 week ago | mlo-online.com | Erin Brady

An Alzheimer’s disease gene therapy has been produced by University of California San Diego School of Medicine scientists “that could help protect the brain from damage and preserve cognitive function,” according to a release. The new therapy could lead researches to “the root cause of Alzheimer’s disease by influencing the behavior of brain cells themselves.” The developers hope their therapy will intervene with Alzheimer's progression. Future studies are needed to test the therapy on humans.
Mayo Clinic study supports FDA-approved Alzheimer's blood test

2 weeks ago | mlo-online.com | Erin Brady

Recent Mayo Clinic research supports the reliability of the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio for diagnosing Alzheimer's, according to a release. The test, recently approved by the FDA, “can be used at outpatient memory clinics to diagnose the disease in patients with a range of cognitive impairment.”Key findings:·The blood test showed accuracy comparable to cerebrospinal fluid biomarkers in an outpatient clinic.
BIDMC scientists say many Americans are unaware they have diabetes, high blood pressure, or high cholesterol

2 weeks ago | mlo-online.com | Erin Brady

A group of specialists from the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) released findings revealing a high amount of adults living in the U.S. don’t know they have diabetes, high blood pressure, or high cholesterol. Key findings:·Percentages of people unaware of these conditions were highest among young adults. ·Hypertension unawareness increased the most. Diabetes and high cholesterol unawareness stayed the same.
HPV self-tests raise cervical cancer screening, study says

2 weeks ago | mlo-online.com | Erin Brady

A new study from The University of Texas MDAnderson Cancer Center found that more women will screen for human papillomavirus (HPV) if they can self-test at home. According to a release, screening rates “more than doubled” among women who are under-screened or had never been screened. More than 2,000 diverse women participated in the study. All were reminded to screen by phone. Some received the self-collection kit while others received a reminder to make an appointment with their clinicians.
Many breast cancer patients choose longer treatment

2 weeks ago | mlo-online.com | Erin Brady

When given the option to prolong hormone-based breast cancer treatment, many patients chose to, new research finds. A new study led by University of Michigan Health Rogel Cancer Center and Stanford Medicine scientists concluded:·Nearly half of early-stage breast cancer patients (47%) decided to extend their treatment to 10 years after finishing five. ·62% of stage 2 patients said they would extend their treatment. ·39% of stage 1 patients were willing to prolong treatment.
ACIP committee to be replaced

2 weeks ago | mlo-online.com | Erin Brady

The U.S. Department of Health and Human Services has announced that all 17 members of the Advisory Committee for Immunization Practices (ACIP) have been dismissed. According to an announcement, new members will be selected, and candidates are already being considered. The goal of this action is to reinstate trust in vaccines and “ensure that government scientific activities are informed by the most credible, reliable, and impartial scientific evidence available.” HHS Secretary Robert F.